PBM Business Practices Come Under Greater Scrutiny

from 4sight Health Roundup (for Healthcare Executives) · host 4sight Health Roundup

New research and a new federal investigation are turning up the heat on PBMs and their role in high drug prices. Will anything come of it for consumers? We talked about it on today's episode of the 4sight Friday Roundup podcast. David Johnson is CEO of 4sight Health. Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution. David Burda is News Editor and Columnist of 4sight Health.

Episode metadata supplied by the publisher feed · Published Jun 10, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

PBM Business Practices Come Under Greater Scrutiny

0:00 19:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 4sight Health Roundup (for Healthcare Executives)?

This episode is 19 minutes long.

When was this 4sight Health Roundup (for Healthcare Executives) episode published?

This episode was published on June 10, 2022.

Can I download this 4sight Health Roundup (for Healthcare Executives) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!